|Articles|August 23, 2022
This week on Contemporary OB/GYN®: August 22 to August 26
Author(s)Lindsey Carr, Editor
What's in store for the week ahead? Ω
Advertisement
This week's features include:
FDA expands approval of Mirena for up to 8 years
After a recent FDA approval, Mirena can be used to prevent pregnancy for up to 8 years.
Gestational diabetes mellitus rate increased from 2016 to 2020
Data from the US Department of Health and Human Services has shown an increase in GDM rate from 2016 to 2020, with a greater increase observed from 2019 to 2020.
Tips for capturing specialty practice revenue
3 tips and tricks for practices looking to boost the bottom line.
Pap Talk podcast: A look inside the new March of Dimes Prematurity Research Center at UC San Francisco
Stay tuned for this week's episode, which features the Center's co-director Dr. Marina Sirota, an associate professor in the Bakar Computational Health Sciences Institute and the department of Pediatrics at UCSF.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
GSK, Spero Therapeutics resubmits NDA for tebipenem HBr as oral option for complicated urinary tract infections
2
Michelle Manzo, MPH, CMPP, discusses epilepsy challenges in motherhood
3
FDA clears FemVue Controlled for in-office tubal assessment
4
FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women
5






